These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11682262)

  • 1. Dopamine partial agonist reverses amphetamine withdrawal in rats.
    Orsini C; Koob GF; Pulvirenti L
    Neuropsychopharmacology; 2001 Nov; 25(5):789-92. PubMed ID: 11682262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of terguride, ropinirole, and acetyl-L-carnitine on methamphetamine withdrawal in the rat.
    Hoefer ME; Voskanian SJ; Koob GF; Pulvirenti L
    Pharmacol Biochem Behav; 2006 Mar; 83(3):403-9. PubMed ID: 16647107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats.
    Schwabe K; Koch M
    Psychopharmacology (Berl); 2007 Apr; 191(3):759-65. PubMed ID: 16953383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule.
    Izzo E; Orsini C; Koob GF; Pulvirenti L
    Pharmacol Biochem Behav; 2001 Apr; 68(4):701-8. PubMed ID: 11526967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dopamine D(2) partial agonist and antagonist terguride decreases heroin self-administration on fixed- and progressive-ratio schedules.
    Zhang D; Wang X; Xiang X; Chen H; Zhang J; Su Q; Hao W
    Pharmacol Biochem Behav; 2010 Dec; 97(2):222-6. PubMed ID: 20705086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats.
    McDougall SA; Hernandez RM; Reichel CM; Farley CM
    Psychopharmacology (Berl); 2005 Apr; 178(4):431-9. PubMed ID: 15765258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine withdrawal decreases responding reinforced by sucrose self-administration in progressive ratio.
    Zhang D; Zhou X; Wang X; Xiang X; Chen H; Hao W
    Addict Biol; 2007 Jun; 12(2):152-7. PubMed ID: 17508986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine-induced withdrawal responding: effects of repeated drug administration.
    Caul WF; Stadler JR; Barrett RJ
    Psychopharmacology (Berl); 1997 Oct; 133(4):351-5. PubMed ID: 9372534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lisuride reduces psychomotor retardation during withdrawal from chronic intravenous amphetamine self-administration in rats.
    Pulvirenti L; Koob GF
    Neuropsychopharmacology; 1993 May; 8(3):213-8. PubMed ID: 8507348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat.
    Pulvirenti L; Balducci C; Piercy M; Koob GF
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1231-8. PubMed ID: 9732383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional differences in the effects of amphetamine withdrawal on dopamine dynamics in the striatum.
    Lee TH; Ellinwood EH; King GR
    Neuropsychopharmacology; 1997 Apr; 16(4):311-4. PubMed ID: 9094149
    [No Abstract]   [Full Text] [Related]  

  • 12. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
    Pierce RC; Kalivas PW
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats.
    Der-Avakian A; Markou A
    Behav Pharmacol; 2010 Jul; 21(4):359-68. PubMed ID: 20571366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.
    Fletcher PJ; Tenn CC; Sinyard J; Rizos Z; Kapur S
    Neuropsychopharmacology; 2007 May; 32(5):1122-32. PubMed ID: 17047670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
    Russig H; Murphy CA; Feldon J
    Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.
    Zhornitsky S; Potvin S; Stip E; Rompré PP
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):695-703. PubMed ID: 20605419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal from chronic amphetamine reduces dopamine transmission in the rat lateral septum.
    Renard GM; Sotomayor-Zarate R; Blanco EH; Gysling K
    J Neurosci Res; 2014 Jul; 92(7):937-43. PubMed ID: 24753218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dopamine agonists and antagonists on the lorazepam withdrawal syndrome in rats.
    Nath C; Saxena RC; Gupta MB
    Clin Exp Pharmacol Physiol; 2000 Mar; 27(3):167-71. PubMed ID: 10744342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adenosine receptor agonists and antagonists in amphetamine-induced conditioned place preference test in rats.
    Poleszak E; Malec D
    Pol J Pharmacol; 2003; 55(3):319-26. PubMed ID: 14506310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.